Page last updated: 2024-08-22

molybdate ion and pervanadate

molybdate ion has been researched along with pervanadate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hwang, SA; Jang, SH; Karnik, SS; Kim, M; Kim, MS; Lee, C; Yun, SH	1

Other Studies

1 other study(ies) available for molybdate ion and pervanadate

Article	Year
A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced beta-arrestin cleavage. Molecules and cells, 2009, Jul-31, Volume: 28, Issue:1 Topics: Angiotensin II; Animals; Arrestins; beta-Arrestin 1; beta-Arrestins; Blotting, Western; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Green Fluorescent Proteins; Hydrolysis; Molybdenum; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatases; Rats; Receptor, Angiotensin, Type 1; Transfection; Tyrosine; Vanadates; Vasoconstrictor Agents	2009

Article

Year

A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced beta-arrestin cleavage.

Molecules and cells, 2009, Jul-31, Volume: 28, Issue:1

Topics: Angiotensin II; Animals; Arrestins; beta-Arrestin 1; beta-Arrestins; Blotting, Western; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Green Fluorescent Proteins; Hydrolysis; Molybdenum; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatases; Rats; Receptor, Angiotensin, Type 1; Transfection; Tyrosine; Vanadates; Vasoconstrictor Agents

2009